Science Explorer Back to mapMap
Discussion
Institution · Aaron Diamond AIDS Research Center

Most cited papers from Aaron Diamond AIDS Research Center

Aaron Diamond AIDS Research Center

What are the most cited papers from Aaron Diamond AIDS Research Center?

The most cited paper from Aaron Diamond AIDS Research Center is "Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection" (David D. Ho, Avidan Uriel Neumann, Alan S. Perelson et al., 1995), with 4,310 citations. Next come "Identification of a major co-receptor for primary isolates of HIV-1" (3,697) and "HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time" (3,587).

Showing 50 of 60 papers. Every paper with more than 521 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection David D. Ho, Avidan Uriel Neumann, Alan S. Perelson et al. · Nature 1995 4,310
2 Identification of a major co-receptor for primary isolates of HIV-1 Hongkui Deng, Rong Liu, Wilfried Ellmeier et al. · Nature Jun 1996 3,697
3 HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time Alan S. Perelson, Avidan Uriel Neumann, Martin H. Markowitz et al. · Science 15 Mar 1996 3,587
4 Extrapulmonary manifestations of COVID-19 Aakriti Gupta et al. · Nature Medicine Open access Jul 2020 3,340
5 HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 Tatjana Dragic, Virginia Litwin, Graham P. Allaway et al. · Nature 20 Jun 1996 3,221
6 Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy Diana Finzi, Monika Hermankova, Theodore C. Pierson et al. · Science 14 Nov 1997 3,163
7 Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection Rong Liu, William A. Paxton, Sunny S. Choe et al. · Cell Open access Aug 1996 3,140
8 A diverse range of gene products are effectors of the type I interferon antiviral response John W. Schoggins, Sam J. Wilson, Maryline Panis et al. · Nature Open access 8 Apr 2011 2,545
9 Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome Richard A. Koup, Jeffrey T. Safrit, Yaming Cao et al. · Journal of Virology Open access Jul 1994 2,515
10 Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Stuart J. D. Neil, Trinity M. Zang, Paul D. Bieniasz · Nature 2008 1,912
11 Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike Lihong Liu et al. · Nature Open access 22 Jul 2020 1,622
12 Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 Lihong Liu et al. · Nature Open access 23 Dec 2021 1,456
13 Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques Xia Jin, Daniel E. Bauer, Sarah Tuttleton et al. · The Journal of Experimental Medicine Open access 15 Mar 1999 1,423
14 Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA Graham Stuart Ogg, Xia Jin, Sebastian Bonhoeffer et al. · Science 27 Mar 1998 1,399
15 Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals Ruth I. Connor, Kristine E. Sheridan, Daniel J. Ceradini et al. · The Journal of Experimental Medicine Open access 17 Feb 1997 1,375
16 The role of a mutant CCR5 allele in HIV–1 transmission and disease progression Yaoxing Huang, William A. Paxton, Steven M. Wolinsky et al. · Nature Medicine Nov 1996 1,371
17 Vpr Is Required for Efficient Replication of Human Immunodeficiency Virus Type-1 in Mononuclear Phagocytes Ruth I. Connor, Benjamin K. Chen, Sunny S. Choe et al. · Virology Open access Feb 1995 1,288
18 Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection Tuofu Zhu, Hongmei Mo, Ning Wang et al. · Science 27 Aug 1993 1,254
19 Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry Matthew J. Evans, Thomas von Hahn, Donna M. Tscherne et al. · Nature 25 Feb 2007 1,208
20 Identification of microRNAs of the herpesvirus family Sébastien Pfeffer, Alain Sewer, Mariana Lagos‐Quintana et al. · Nature Methods 16 Feb 2005 1,166
21 Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract Saurabh Mehandru, Michael A. Poles, Klara Tenner‐Racz et al. · The Journal of Experimental Medicine Open access 13 Sep 2004 1,158
22 Antiretroviral-Drug Resistance among Patients Recently Infected with HIV Susan J. Little, Sarah Holte, Jean‐Pierre Routy et al. · New England Journal of Medicine Open access 8 Aug 2002 1,148
23 Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 Alexandra Trkola, Martin Purtscher, Thomas Muster et al. · Journal of Virology Open access Feb 1996 1,125
24 Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody Dennis R. Burton, Jayashree Pyati, Raju K. Koduri et al. · Science 11 Nov 1994 1,106
25 CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 Alexandra Trkola, Tatjana Dragic, James A. Arthos et al. · Nature Nov 1996 1,049
26 Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection Yunzhen Cao, Limo Qin, Linqi Zhang et al. · New England Journal of Medicine Open access 26 Jan 1995 1,044
27 Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Qian Wang, Sho Iketani, Zhiteng Li et al. · Cell Open access 14 Dec 2022 962
28 Recognition of bacterial glycosphingolipids by natural killer T cells Yuki Kinjo, Douglass Wu, Gisen Kim et al. · Nature Mar 2005 931
29 Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity Julian He, S Choe, Robert Walker et al. · Journal of Virology Open access Nov 1995 926
30 Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals Johannes F. Scheid et al. · Nature 15 Mar 2009 881
31 HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function Victor Appay, Douglas F. Nixon, Sean M. Donahoe et al. · The Journal of Experimental Medicine Open access 3 Jul 2000 874
32 Antibody evasion properties of SARS-CoV-2 Omicron sublineages Sho Iketani, Lihong Liu, Yicheng Guo et al. · Nature Open access 3 Mar 2022 862
33 Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 Qian Wang, Yicheng Guo, Sho Iketani et al. · Nature Open access 5 Jul 2022 860
34 Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection Eric S. Daar, Tarsem Lal Moudgil, Richard D. Meyer et al. · New England Journal of Medicine Open access 4 Apr 1991 846
35 A new classification for HIV-1 Edward A. Berger, Robert W. Doms, E M Fenyö et al. · Nature 15 Jan 1998 833
36 Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy Linqi Zhang, Bharat Ramratnam, Klara Tenner‐Racz et al. · New England Journal of Medicine Open access 27 May 1999 828
37 Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection Jesus F. Salazar-Gonzalez et al. · The Journal of Experimental Medicine Open access Jun 2009 798
38 Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles Mayla Hsu, Jie Zhang, Mike Flint et al. · Proceedings of the National Academy of Sciences Open access 21 May 2003 783
39 Ordered accumulation of mutations in HIV protease confers resistance to ritonavir Akhteruzzaman Molla, Marina Korneyeva, Qing Chun Gao et al. · Nature Medicine Jul 1996 771
40 AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor George A. Donzella, Dominique Schols, Steven Lin et al. · Nature Medicine 1998 769
41 HIV/AIDS epidemiology, pathogenesis, prevention, and treatment Viviana R. Simon, David D. Ho, Quarraisha Abdool Karim · The Lancet Open access Aug 2006 733
42 HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress Juan Martin‐Serrano, Trinity M. Zang, Paul D. Bieniasz · Nature Medicine Dec 2001 714
43 CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro Lijun Wu, William A. Paxton, Nasim Kassam et al. · The Journal of Experimental Medicine Open access 5 May 1997 711
44 Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain Christopher R. Aiken, Jason A. Konner, Nathaniel Roy Landau et al. · Cell Mar 1994 705
45 Endogenous Viral Elements in Animal Genomes Aris Katzourakis, Robert James Gifford · PLoS Genetics Open access 18 Nov 2010 704
46 Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. Alexander I. Spira, Preston A. Marx, Bruce Kendrick Patterson et al. · The Journal of Experimental Medicine Open access 1996 697
47 Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection Roy T. Steigbigel et al. · New England Journal of Medicine Open access 23 Jul 2008 690
48 A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids Liuliu Yang et al. · Cell stem cell Open access 19 Jun 2020 681
49 Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro Paul W.H.I. Parren, Preston A. Marx, Ann Jones Hessell et al. · Journal of Virology Open access Sep 2001 669
50 CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 Michael J Endres, Paul R. Clapham, Mark Marsh et al. · Cell Open access Nov 1996 665

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.